U.S. Diabetic Neuropathy Treatment Market, 2023-2030

Name: U.S. Diabetic Neuropathy Treatment Market
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The diabetic neuropathy treatment market in the United States is expected to reach a projected revenue of US$ 2,198.9 million by 2030. A compound annual growth rate of 6.5% is expected of the United States diabetic neuropathy treatment market from 2024 to 2030.

Pharmaceuticals
- Metabolic Disorders Treatment
  - diabetic neuropathy treatment market report

U.S. diabetic neuropathy treatment report disorder type outlook (Revenue, USD million, 2018-2030)
- Peripheral Neuropathy
- Autonomic Neuropathy
- Proximal Neuropathy
- Focal Neuropathy
U.S. diabetic neuropathy treatment report drug class outlook (Revenue, USD million, 2018-2030)
- Capsaicin
- Opioid
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Antidepressants
- Other Drug Class
U.S. diabetic neuropathy treatment report distribution channel outlook (Revenue, USD million, 2018-2030)
- Hospital Pharmacies
- Retail Pharmacies
- Others Distribution Channel

U.S. Diabetic Neuropathy Treatment Market, 2023-2030

Data Tree

Sign up - it's easy, and free!